The NCCR*Explorer application uses the International Classification of Childhood Cancer (ICCC) coding schema to classify cancer cases.
The ICCC Recode Third Edition ICD-O-3/IARC 2017 has the definitions for each cancer site.
To compare multiple cancer sites on the same graph, select the Compare Cancer Sites option.
Select from the list or begin typing a cancer site name to find the available sites that match your term.
Incidence is the number of new cases of the specific cancer site/type per 1,000,000 people in the U.S.
Cancer Mortality is the number of deaths caused by a specific cancer site/type per 1,000,000 people in the U.S.
Relative survival is an estimate of the percentage of patients who would be expected to survive the effects of their cancer.
Cancer Prevalence is the number or percent of people alive on a certain date who have been diagnosed with cancer.
Risk of Diagnosis/Dying
Lifetime risk is the probability of developing or dying from cancer in the course of one's lifespan.
Trends Over Time
Recent trends present the observed (points) and modeled (lines) annual age-adjusted rates and corresponding annual percent change (APC) trend for each joinpoint segment in the table.
Recent rates present the age-adjusted rate for the aggregated five most recent years of the available data, in a bar chart format.
Rates by Age
Rates by age refer to a rate for a single age for the most recent 5-year time period.
Recent trends present observed (points) and predicted (lines) relative survival by time since diagnosis (1 year, 3 years, 5 years) and corresponding trend shown in table.
5-year relative survival rates show the estimated percentage of patients who would be expected to survive the effects of their cancer 5 years or more after cancer diagnosis.
By Time Since Diagnosis
Survival by time since diagnosis provides a view of the percentage of people surviving by year after diagnosis in up to 10 years.
Conditional survival show the 5-year relative survival rates for patients conditioned on the patient having already survived 0, 1, 3, or 5 years since the cancer diagnosis.
Complete prevalence represents the proportion of people alive on a certain day who previously had a diagnosis of the disease, regardless of how long ago the diagnosis was, or whether the patient is still under treatment or is considered cured.
Limited-duration prevalence represents the proportion of people alive on a certain day who had a diagnosis of the disease within the past 25 years.
URL Copied to Clipboard
Tap on points for more details.
To learn more about the NCCR*Explorer and how to use all of its special features, you can visit our Help page.
Want to see what has changed with the NCCR*Explorer application? Visit the revision history page to view details on all the most recent releases to NCCR*Explorer.
Download and Share
This functionality is not fully supported in Internet Explorer. Please use a different browser or take a screenshot.